bioRxiv Science⌕ Search

Biology subjects

Rost, G.

Publications and source records attributed to Rost, G..

8 recordsLinked to original sources

Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection

The main question in model selection for longitudinal RT-qPCR data is whether improvements in fit justify the additional parameters of more complex within-host models. We compared a target-cell-limited model (TIV), an eclipse-phase extension (TEIV), and a fractional-order TIV using infection waves reconstructed from SARS-CoV-2 cycle-threshold (Ct) measurements in a National Basketball Association cohort. Each trajectory was fitted on the Ct scale by maximizing a right-censored Gaussian likelihood using hybrid global-local optimization. Model selection was based primarily on the small-sample corrected Akaike information criterion (AICc), computed from the censored likelihood; while robustness to the choice of information criterion was assessed using the Akaike information criterion (AIC) and Bayesian information criterion (BIC). Among 868 evaluable trajectories, the unpenalized likelihood ranking identified TEIV as the clear best-fitting model in 34.0% of cases, fr-TIV in 30.2%, and TIV in 3.3%; the remaining 32.5% were effectively tied. After accounting for model complexity, AICc clearly favored TIV in 97.8% of trajectories and fr-TIV in 0.5%, while 1.7% were effectively tied; TEIV was not a clear winner in any of the trajectories. Thus, for these short, sparsely sampled Ct-only trajectories, TIV provided the best-supported parsimonious effective description. This does not imply that eclipse-phase or memory-like dynamics are biologically absent, but rather that the simpler TIV model is favoured by standard information criteria for the limited information contained in these data.

systems biology↗

A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma

Large B-cell lymphomas (LBCLs) are a clinically and molecularly diverse group of malignancies with a rapidly evolving therapeutic landscape that has introduced new areas of clinical need such as post-CD19 chimeric antigen receptor T (CART19) progression. Patient derived xenograft (PDX) models are an important tool for mechanistic studies and preclinical evaluation of new therapies and can be generated from a variety of clinical contexts that capture tumor-intrinsic resistance mechanisms. We therefore undertook a comprehensive effort to generate PDX models that encompass the molecular landscape of LBCLs and include important clinical scenarios for new drug development. Here we describe the first 48 models within this publicly available repository, capturing the transcriptional and genetic subsets of LBCL. These models also include 23 generated from post-CART progression biopsies which reproduce patterns of progression driven by CD19 mutation or expression loss, as well as tumor cell-intrinsic CART19 resistance that we validate in vivo. STATEMENT OF SIGNIFICANCEYang et al. describe X-LYMPH (Xenografts of Lymphoma), a publicly available and molecularly annotated PDX repository that captures the heterogeneity of large B-cell lymphoma. X-LYMPH includes models of chimeric antigen receptor T cell resistance, providing a shared foundation for mechanistic research and therapeutic development for lymphomas.

cancer biology↗

Evolution into chaos - implications of the trade-off between transmissibility and immune evasion

Predicting viral evolution presents a significant challenge and is a critical public health priority. In response to this challenge, we develop a novel model for viral evolution that considers a trade-off between immunity evasion and transmissibility. The model selects for a new strain with the highest invasion fitness, taking into account this trade-off. When the dominant strain of the pathogen is highly transmissible, evolution tends to favor immune evasion, whereas for less contagious strains the direction of evolution leads toward increasing transmissibility. Assuming a linear functional form of this trade-off, we can express the long-term evolutionary patterns following the emergence of subsequent strains by a non-linear difference equation. We provide sufficient criteria for when evolution converges, and successive strains exhibit similar transmissibility. We also identify scenarios characterized by a two-periodic pattern in upcoming strains, indicating a situation where a highly transmissible but not immune-evasive strain is replaced by a less transmissible but highly immune-evasive strain, and vice versa, creating a cyclic pattern. Finally, we show that under certain conditions, viral evolution becomes chaotic and thus future transmissibilites become unpredictable in the long run. Visualization via bifurcation diagrams elucidates our analytical findings, revealing complex dynamic behaviors that include the presence of multiple periodic solutions and extend to chaotic regimes. Our analysis provides valuable insights into the complexities of viral evolution in the light of the trade-off between immune evasion and transmissibility.

evolutionary biology↗

Waiting for the Perfect Vaccine

Vaccination has proven to be the most effective public health measure in the fight against various infectious diseases. For emerging or re-emerging diseases, a highly efficacious vaccine may not be available at the start of an outbreak. Timelines for availability of a safe and effective vaccine may significantly affect disease dynamics, its burden, and the healthcare resource utilization. Mitigating this impact may then rely on low-efficacy vaccines that may be rapidly produced and distributed to at-risk populations at the early stages of an outbreak. With the expectation for arrival of a more effective vaccine at a later stage of the outbreak, the optimal vaccination coverage with the existing, low-efficacy vaccines is elusive. While flattening the outbreak if a significant proportion of the susceptible population is vaccinated with a low-efficacy vaccine, the overall infections may not be minimized if a small proportion of the population left unvaccinated when a highly efficacious vaccine becomes available. The optimal coverage for early vaccination could thus depend on several parameters including the efficacy of the currently available vaccines, arrival timing of a more effective vaccine and its efficacy, and the transmissbility of the disease. Here, we develop a deterministic system of differential equations to investigate the optimal vaccination coverage with a low-efficacy vaccine within the aforementioned parameter space. Despite simplifying assumptions, we illustrate that minimizing the overall infections does not necessarily correspond to the highest coverage of early vaccination. However, a high vaccination coverage, even with a low-efficacy vaccine, may still contribute to alleviating severe disease outcomes and reducing healthcare resource utilization.

systems biology↗

Epidemic patterns of emerging variants with dynamical social distancing

Motivated by the emergence of new variants during the COVID-19 pandemic, we consider an epidemiological model of disease transmission dynamics, where novel strains appear by mutations of the virus. In the considered scenarios, disease prevalence in the population is modulated by social distancing. We study the various patterns that are generated under different assumptions of cross-immunity. If recovery from a given strain provides immunity against all previous strains, but not against more novel strains, then we observe a very regular sequential pattern of strain replacement where newer strains predominate over older strains. However, if protection upon recovery holds only against that particular strain and none of the others, we find much more complicated dynamics with potential recurrence of earlier strains, and co-circulation of various strains. We compare the observed patterns with genomic analysis we have seen during the COVID-19 pandemic.

evolutionary biology↗

Exotic bifurcations in three connected populations with Allee effect

We consider three connected populations with strong Allee effect, and give a complete classification of the steady state structure of the system with respect to the Allee threshold and the dispersal rate, describing the bifurcations at each critical point where the number of steady states change. One may expect that by increasing the dispersal rate between the patches, the system would become more well-mixed hence simpler. However, we show that it is not always the case, and the number of steady states may (temporarily) increase by increasing the dispersal rate. Besides sequences of pitchfork and saddle-node bifurcations, we find triple-transcritical bifurcations and also a sun-ray shaped bifurcation where twelve steady states meet at a single point then disappear. The major tool of our investigations is a novel algorithm that decomposes the parameter space with respect to the number of steady states and find the bifurcation values using cylindrical algebraic decomposition with respect to the discriminant variety of the polynomial system.

ecology↗

Global analysis of a cancer model with drug resistance due to Lamarckian induction and microvesicle transfer

Development of resistance to chemotherapy in cancer patients strongly effects the outcome of the treatment. Due to chemotherapeutic agents, resistance can emerge by Darwinian evolution. Besides this, acquired drug resistance may arise via changes in gene expression. A recent discovery in cancer research uncovered a third possibility, indicating that this phenotype conversion can occur through the transfer of microvesicles from resistant to sensitive cells, a mechanism resembling the spread of an infectious agent. We present a model describing the evolution of sensitive and resistant tumour cells considering Darwinian selection, Lamarckian induction and microvesicle transfer. We identify three threshold parameters which determine the existence and stability of the three possible equilibria. Using a simple Dulac function, we give a complete description of the dynamics of the model depending on the three threshold parameters. We demonstrate the possible effects of increasing drug concentration, and characterize the possible bifurcation sequences. Our results show that the presence of microvesicle transfer cannot ruin a therapy that otherwise leads to extinction, however it may doom a partially successful therapy to failure.

cancer biology↗

Temporal evolution of immunity distributions in a population with waning and boosting

We investigate the temporal evolution of the distribution of immunities in a population, which is determined by various epidemiological, immunological and demographical phenomena: after a disease outbreak, recovered individuals constitute a large immune population, however their immunity is waning in the long term and they may become susceptible again. Meanwhile, their immunity can be boosted by repeated exposure to the pathogen, which is linked to the density of infected individuals present in the population. This prolongs the length of their immunity.\n\nWe consider a mathematical model formulated as a coupled system of ordinary and partial differential equations, that connects all these processes, and systematically compare a number of boosting assumptions proposed in the literature, showing that different boosting mechanisms lead to very different stationary distributions of the immunity at the endemic steady state. In the situation of periodic disease outbreaks, the waveforms of immunity distributions are studied and visualized. Our results show that there is a possibility to infer the boosting mechanism from the population level immune-dynamics.\n\nAMS Classification92D30, 34K60, 34K34, 37M05

epidemiology↗